retatrutide clinical trials phase 3 for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational - Giblin - 2026 - Diabetes, Obesity and Metabolism Retatrutide for weight loss: Study

ATF6-mediated signaling contributes to PARP inhibitor resistance in ovarian cancer

It is estimated that about 50% of men at the age of 60 have histological benign prostatic hyperplasia (BPH)/LUTS, approximately 7080% of men aged 6089 years are affected, and by 90, the prevalence approaches 90% ( Although LUTS appears to be more prevalent in the elderly than in younger persons, they should not be considered a normal aspect of aging

Unlike semaglutide, which only targets GLP-1 receptors, tirzepatide is a dual agonist that targets GLP-1 and glucagon receptors

I don't know my blood type -- is that a problem

It plays a role in the transportation and metabolization of lipids (fat)